158 related articles for article (PubMed ID: 18627323)
1. Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women.
Uchikova E; Pehlivanov B
Expert Opin Pharmacother; 2008 Aug; 9(11):1839-44. PubMed ID: 18627323
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
Winkler UH; Schindler AE; Endrikat J; Düsterberg B
Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
[TBL] [Abstract][Full Text] [Related]
3. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
Norris LA; Bonnar J
Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
[TBL] [Abstract][Full Text] [Related]
4. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Petersen KR; Sidelmann J; Skouby SO; Jespersen J
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
6. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
Ferreira AC; Montes MB; Franceschini SA; Toloi MR
Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
[TBL] [Abstract][Full Text] [Related]
7. A 12-month clinical investigation with a 24-day regimen containing 15 microg ethinylestradiol plus 60 microg gestodene with respect to hemostasis and cycle control.
Fruzzetti F; Genazzani AR; Ricci C; De Negri F; Bersi C; Carmassi F
Contraception; 2001 Jun; 63(6):303-7. PubMed ID: 11672551
[TBL] [Abstract][Full Text] [Related]
8. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
Endrikat J; Müller U; Düsterberg B
Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
[TBL] [Abstract][Full Text] [Related]
9. [Hemostatic balance during treatment with the newest contraceptives].
Petersen KR; Skouby SO; Sidelmann J; Jespersen J
Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
[TBL] [Abstract][Full Text] [Related]
10. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
11. [The effect of two low dose oral contraceptive with gestodene on the systems of natural inhibitors of coagulation].
Uchikova E; Terzhumanov R; Milchev N; Iacheva T
Akush Ginekol (Sofiia); 2004; 43(6):19-23. PubMed ID: 15669648
[TBL] [Abstract][Full Text] [Related]
12. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
13. Effects of two combined monophasic and triphasic ethinylestradiol/gestodene oral contraceptives on natural inhibitors and other hemostatic variables.
Creatsas G; Kontopoulou-Griva I; Deligeoroglou E; Digenopoulou L; Tsangaris A; Kallipolitis G; Milingos S; Michalas S
Eur J Contracept Reprod Health Care; 1997 Mar; 2(1):31-8. PubMed ID: 9678107
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomized, crossover study.
Junge W; Heger-Mahn D; Trummer D; Merz M
Drugs R D; 2013 Sep; 13(3):223-33. PubMed ID: 24043457
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
[TBL] [Abstract][Full Text] [Related]
16. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
Prasad RN; Koh SC; Viegas OA; Ratnam SS
Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
Abbate R; Pinto S; Rostagno C; Bruni V; Rosati D; Mariani G
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
[TBL] [Abstract][Full Text] [Related]
18. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
[TBL] [Abstract][Full Text] [Related]
19. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
Fruzzetti F; Ricci C; Fioretti P
Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
[TBL] [Abstract][Full Text] [Related]
20. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Bonnar J; Daly L; Carroll E
Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]